Drug intelligence / Profile preview

Eurican L4

Development stage
Unknown
Lead developer
Boehringer Ingelheim
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Eurican L4 is an inactivated immunological veterinary vaccine designed for the active immunisation of dogs against leptospirosis. It contains inactivated strains from four key Leptospira serogroups and serovars—Canicola (strain 16070), Icterohaemorrhagiae (strain 16069), Grippotyphosa (Grippo Mal 1540), and Australis/Bratislava (strain 16785). The vaccine aims to prevent or reduce mortality, clinical signs, infection, bacterial excretion, renal carriage, and renal lesions caused by these Leptospira species. It is administered as a subcutaneous injection starting at seven weeks of age with a booster after four weeks and then annually. The product does not contain an adjuvant[1][2][3][5][6].

Brand names
Eurican L4
02

Targets

L. icterohaemorrhagiae (Leptospira interrogans serovar Icterohaemorrhagiae)Leptospira interrogans serogroup Canicola antigensLeptospira interrogans serogroup Australis antigens

Beyond the preview

Go deeper on Eurican L4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurican L4.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call